About 57 people are diagnosed with breast cancer every day in Australia, with instances having grown over the past decade. New and improved treatments are crucial, and to address that, Australian diagnostics company INOVIQ (ASX: IIQ) has developed a special exosome therapy that can target and kill breast cancer cells in lab tests. The Company
Read More
Biotech company Argenica Therapeutics Limited (ASX: AGN), which is developing novel therapeutics to reduce brain tissue death after stroke, has completed the production of its neuroprotective peptide candidate ARG-007 in powder form. The Company is gearing up for its Phase 2 clinical trials, and the final manufacturing of the sterile drug product in vials is
Read More
Us humans are in the near constant pursuit of ever increasing efficaciousness, especially in the field of medicine. How can we harness the best possible patient outcome in the least amount of time? Theranostics is a field of medicine combining both therapeutics and diagnostic measures to tackle the most complex medical burdens of today. Since
Read More
Furthering their expertise in the field of cannabinoid-based therapeutics, Zelira Therapeutics (ASX: ZLD) is set to tap into the oral care market with the launch of hemp derived toothpaste in the United States. The toothpaste formulation was created by Sprinjene CEO and Founder, Dr Sayed Abrahim who developed the oral care product which is gluten-free,
Read More